← All companies

AMPH

Amphastar Pharmaceuticals, Inc.

AMPH Nasdaq Pharmaceutical Preparations EDGAR ↗

$20.22

-0.16 -0.79%

Key statistics

from XBRL data in SEC filings

Market cap

$892M

Revenue (TTM)

$721M

Net income (TTM)

$79.2M

EPS (TTM)

$1.66

P/E ratio

12.2

Dividend yield

—

Free cash flow

$121M

Cash

$171M

Total assets

$1.65B

Gross margin

47.3%

52-week range

$16.65 – $31.26

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 13, 2026 8-K Other events Jul 8, 2026 8-K Shareholder vote results Jun 3, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Other events Mar 16, 2026 8-K Director or officer change Mar 6, 2026 8-K Entered a material agreement Mar 6, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Entered a material agreement; Regulation FD disclosure Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Entered a material agreement Oct 24, 2025 8-K Entered a material agreement Sep 18, 2025 8-K Entered a material agreement; Regulation FD disclosure Aug 12, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Director or officer change Jul 21, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 4, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Results of operations (earnings release) Feb 27, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Entered a material agreement Aug 30, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Director or officer change; Shareholder vote results; Other events Jun 4, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release) May 8, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release) Feb 28, 2024 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Results of operations (earnings release) Nov 8, 2023 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Sep 15, 2023 8-K/A Aug 16, 2023 10-Q Quarter ended 2023-06-30 Aug 9, 2023 8-K Results of operations (earnings release) Aug 8, 2023